Bourguignon Lilly Y W, Singleton Patrick A, Zhu Hongbo, Diedrich Falko
Department of Medicine, University of California at San Francisco and the Endocrine Unit (111N), Veterans Affairs Medical Center, San Francisco, Calfornia 94121, USA.
J Biol Chem. 2003 Aug 8;278(32):29420-34. doi: 10.1074/jbc.M301885200. Epub 2003 May 14.
In this study we have examined CD44 (a hyaluronan (HA) receptor) interaction with a RhoA-specific guanine nucleotide exchange factor (p115RhoGEF) in human metastatic breast tumor cells (MDA-MB-231 cell line). Immunoprecipitation and immunoblot analyses indicate that both CD44 and p115RhoGEF are expressed in MDA-MB-231 cells and that these two proteins are physically associated as a complex in vivo. The binding of HA to MDA-MB-231 cells stimulates p115RhoGEF-mediated RhoA signaling and Rho kinase (ROK) activity, which, in turn, increases serine/threonine phosphorylation of the adaptor protein, Gab-1 (Grb2-associated binder-1). Phosphorylated Gab-1 promotes PI 3-kinase recruitment to CD44v3. Subsequently, PI 3-kinase is activated (in particular, alpha, beta, gamma forms but not the delta form of the p110 catalytic subunit), AKT signaling occurs, the cytokine (macrophage-colony stimulating factor (M-CSF)) is produced, and tumor cell-specific phenotypes (e.g. tumor cell growth, survival and invasion) are up-regulated. Our results also demonstrate that HA/CD44-mediated oncogenic events (e.g. AKT activation, M-CSF production and breast tumor cell-specific phenotypes) can be effectively blocked by a PI 3-kinase inhibitor (LY294002). Finally, we have found that overexpression of a dominant-negative form of ROK (by transfection of MBA-MD-231 cells with the Rho-binding domain cDNA of ROK) not only inhibits HA/CD44-mediated RhoA-ROK activation and Gab-1 phosphorylation but also down-regulates oncogenic signaling events (e.g. Gab-1.PI 3-kinase-CD44v3 association, PI 3-kinase-mediated AKT activation, and M-CSF production) and tumor cell behaviors (e.g. cell growth, survival, and invasion). Taken together, these findings strongly suggest that CD44 interaction with p115RhoGEF and ROK plays a pivotal role in promoting Gab-1 phosphorylation leading to Gab-1.PI 3-kinase membrane localization, AKT signaling, and cytokine (M-CSF) production during HA-mediated breast cancer progression.
在本研究中,我们检测了人转移性乳腺癌细胞(MDA-MB-231细胞系)中CD44(一种透明质酸(HA)受体)与RhoA特异性鸟嘌呤核苷酸交换因子(p115RhoGEF)的相互作用。免疫沉淀和免疫印迹分析表明,CD44和p115RhoGEF在MDA-MB-231细胞中均有表达,且这两种蛋白在体内以复合物形式物理结合。HA与MDA-MB-231细胞的结合刺激了p115RhoGEF介导的RhoA信号传导和Rho激酶(ROK)活性,进而增加了衔接蛋白Gab-1(Grb2相关结合蛋白-1)的丝氨酸/苏氨酸磷酸化。磷酸化的Gab-1促进PI 3激酶募集到CD44v3。随后,PI 3激酶被激活(特别是p110催化亚基的α、β、γ形式,而非δ形式),AKT信号传导发生,细胞因子(巨噬细胞集落刺激因子(M-CSF))产生,肿瘤细胞特异性表型(如肿瘤细胞生长、存活和侵袭)上调。我们的结果还表明,HA/CD44介导的致癌事件(如AKT激活、M-CSF产生和乳腺癌细胞特异性表型)可被PI 3激酶抑制剂(LY294002)有效阻断。最后,我们发现过表达显性负性形式的ROK(通过用ROK的Rho结合域cDNA转染MBA-MD-231细胞)不仅抑制HA/CD44介导的RhoA-ROK激活和Gab-1磷酸化,还下调致癌信号事件(如Gab-1.PI 3激酶-CD44v3结合、PI 3激酶介导的AKT激活和M-CSF产生)以及肿瘤细胞行为(如细胞生长、存活和侵袭)。综上所述,这些发现强烈表明,在HA介导的乳腺癌进展过程中,CD44与p115RhoGEF和ROK的相互作用在促进Gab-1磷酸化从而导致Gab-1.PI 3激酶膜定位、AKT信号传导和细胞因子(M-CSF)产生方面起着关键作用。